ArticleRheumatology and therapy2025

A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 Weeks.

Suzy van Sanden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.